Salud financiera de hoja de balance de Morepen Laboratories
Salud financiera controles de criterios 6/6
Morepen Laboratories tiene un patrimonio de accionistas total de ₹11.1B y una deuda total de ₹334.9M, lo que sitúa su ratio deuda-patrimonio en 3%. Sus activos y pasivos totales son ₹15.6B y ₹4.5B respectivamente. El BAIT de Morepen Laboratories es de ₹1.8B, por lo que su ratio de cobertura de intereses es de 65.5. Tiene efectivo e inversiones a corto plazo que ascienden a ₹1.9B.
Información clave
3.0%
Ratio deuda-patrimonio
₹334.95m
Deuda
| Ratio de cobertura de intereses | 65.5x |
| Efectivo | ₹1.86b |
| Patrimonio | ₹11.10b |
| Total pasivo | ₹4.52b |
| Activos totales | ₹15.62b |
Actualizaciones recientes sobre salud financiera
Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?
Jun 13
Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly
Nov 23Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
Aug 10Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
May 21Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet
Jan 03
Recent updates
There's Reason For Concern Over Morepen Laboratories Limited's (NSE:MOREPENLAB) Massive 30% Price Jump
Aug 20Impressive Earnings May Not Tell The Whole Story For Morepen Laboratories (NSE:MOREPENLAB)
Aug 09Improved Earnings Required Before Morepen Laboratories Limited (NSE:MOREPENLAB) Stock's 29% Jump Looks Justified
Jul 05Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?
Jun 13Morepen Laboratories Limited's (NSE:MOREPENLAB) Popularity With Investors Is Under Threat From Overpricing
Apr 23Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly
Nov 23Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 22Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
Aug 10Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 21Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?
Apr 05Do Morepen Laboratories's (NSE:MOREPENLAB) Earnings Warrant Your Attention?
Sep 14Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
May 21Does Morepen Laboratories (NSE:MOREPENLAB) Deserve A Spot On Your Watchlist?
Mar 12Our View On Morepen Laboratories' (NSE:MOREPENLAB) CEO Pay
Feb 22Is Morepen Laboratories Limited's (NSE:MOREPENLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Feb 07Morepen Laboratories (NSE:MOREPENLAB) Shareholders Have Enjoyed A 91% Share Price Gain
Jan 21Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet
Jan 03Is There More To The Story Than Morepen Laboratories's (NSE:MOREPENLAB) Earnings Growth?
Dec 16Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?
Nov 28Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹10.9B) de MOREPENLAB superan a sus pasivos a corto plazo (₹4.1B).
Pasivo a largo plazo: Los activos a corto plazo de MOREPENLAB (₹10.9B) superan a sus pasivos a largo plazo (₹453.2M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: MOREPENLAB tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de MOREPENLAB ha pasado de 64.2% a 3% en los últimos 5 años.
Cobertura de la deuda: La deuda de MOREPENLAB está bien cubierta por el flujo de caja operativo (144.2%).
Cobertura de intereses: Los pagos de intereses de la deuda de MOREPENLAB están bien cubiertos por el BAIT (65.5x cobertura).